Intelligence · Clinical Development
Pipeline search results
Programs matching “prostate-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 133 pipeline programs matching "prostate-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Docetaxel
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Prostate biopsy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
TRT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Whole Body Non-Contrast MRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
XMYY-2025KY231
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
zoledronate therapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.